ECDC and WHO call for improved HIV testing in Europe
The number of people living with undiagnosed HIV is increasing in the WHO European Region. According to data published today by ECDC and the WHO/Europe, more than 136 000 people were newly diagnosed in 2019 – roughly 20% of these were diagnosed in the EU/EAA and 80% in the eastern part of the European Region. Every second HIV diagnosis (53%) happens at a late stage of the infection, when the immune system has already started to fail. This is a sign that testing strategies in the Region are not working properly to diagnose HIV early.
The number of people diagnosed with AIDS, the end-stage of an untreated HIV infection, has gone down by more than half in the last decade and the Sustainable Development Goal (SDG) target of ending the AIDS epidemic by 2030 is achievable. However, in the EU/EEA for example, 74% of the 2 772 AIDS diagnoses in 2019 were made very soon after the initial HIV diagnosis – within three months. This shows a significant problem with late diagnosis of HIV infection. Late diagnosis contributes to ongoing HIV transmission as, often for years at a time, people do not know they have HIV and are not getting treatment.
Although the trend across the Region as a whole has stabilised in recent years, the number of people newly diagnosed with HIV has increased by 19% since 2010. In contrast, the proportion of new diagnoses across EU/EEA countries has declined by 9% over the same period.
The number of newly reported HIV diagnoses and the estimated number of new HIV infections in the whole WHO European Region show that more people have become infected with HIV over the last decade than have been diagnosed, indicating that the number of people living with undiagnosed HIV is increasing in the Region. In the EU/EEA, the opposite trend has been observed: the number of people living with undiagnosed HIV has been falling.
ECDC Director Dr Andrea Ammon highlights:
“Despite the focus on COVID-19 right now, we must not lose sight of other public health issues like HIV. Earlier diagnosis of HIV is an urgent priority. We cannot reach the Sustainable Development Goal target if takes an average of three years for people to find out that they are HIV-positive after infection with the virus. Three years during which live-saving treatment is not available to them and during which they can unknowingly pass on HIV. If we want to reduce the high proportion of people diagnosed late, it is essential to diversify our HIV testing strategies as outlined in the ECDC testing guidance, for example.”
Dr Hans Kluge, WHO Regional Director for Europe, says:
“I remember when a diagnosis of HIV seemed like a death sentence. Now, with proper treatment, people with HIV can live without fear of AIDS. These data are from 2019, and the question in 2020 has to be what effect the pandemic will have had on testing by the end of 2021. For now, our message has to be to protect the progress of the last decade by continuing to prioritize HIV testing and getting treatment to those who need it. We cannot allow the pandemic to rob us of an AIDS-free future that is within our grasp.”
Early diagnosis: higher life expectancy and less transmission
The HIV/AIDS surveillance data for 2019 show that the proportion of those who are diagnosed late increases with age. Across the whole Region, 67% (EU/EEA: 65%) of people aged 50 years and older were diagnosed late in the course of their HIV infection. In 2019, one in five new HIV diagnoses was in a person over 50 years of age.
The reasons for this are not yet fully understood. It may be that older adults themselves, or the healthcare workers looking after them, underestimate the risk of infection. Older adults may be more affected by the stigma associated with the disease and less comfortable asking to be tested.
WHO/Europe and ECDC stress that to reduce the number of future HIV infections, Europe needs to focus on three main areas:
- Prioritising a range of prevention measures, such as awareness-raising, promotion of safer sex, condoms, provision of needle exchange programmes and opioid substitution therapy, and pre-exposure prophylaxis for HIV, also known as PrEP;
- Providing efficient HIV counselling and testing services, including rapid diagnostic services, community-based HIV testing and HIV self-testing; and
- Ensuring rapid access to quality treatment and care for those diagnosed.
Early diagnosis is important because it allows people to start HIV treatment sooner, which in turn increases their chances of living a long and healthy life and prevents further transmission.
Guidance to improve testing in Europe
In their guidelines, both WHO/Europe and ECDC recommend that HIV testing services include self-testing and community-based testing by lay providers using rapid tests.
HIV/AIDS surveillance in Europe 2020 (2019 data)
This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been summarizing data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.
World AIDS Day 2020: The way towards 2030: diversified testing to diagnose HIV early
One of the targets of the Sustainable Development Goals is to end the AIDS epidemic by 2030. Still, 2 094 AIDS cases were reported in the EU/EEA during 2019. This shows a significant problem with late diagnosis of HIV infection. Detecting HIV only years after the infection is one reason for on-going transmission in Europe. One in every four AIDS cases occurred long after HIV diagnosis, indicating insufficient linkage to HIV care, access to antiretroviral treatment and adherence support.
Eurosurveillance: Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020
The coronavirus disease (COVID-19) continues to challenge healthcare systems across the World Health Organization (WHO) European Region. As World AIDS Day 2020 approaches, it serves as a reminder about the importance to maintain a strong HIV response at all levels. Further, as framed in the Sustainable Development Goals (SDGs) and recent European and global guidance, it is critical to approach testing for HIV, hepatitis B (HBV), hepatitis C (HCV), and sexually transmitted infections (STIs), namely chlamydia, syphilis and gonorrhoea, in an integrated and synergistic manner.
Infographic: Reported HIV transmission modes in the EU/EEA 2019
This infographic shows a map of EU/EEA with the reported HIV transmissions modes in the various countries.Read more
Infographic: HIV transmission risk patterns in Europe
This infographic shows the various transmission modes and patterns in EuropeRead more